Minoru Yoshiyama
Overview
Explore the profile of Minoru Yoshiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
364
Citations
3796
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imano H, Hayashi T, Nomura A, Tanaka S, Kohda Y, Yamaguchi T, et al.
Hypertens Res
. 2024 Oct;
47(12):3423-3433.
PMID: 39367269
Pulmonary arterial hypertension (PAH) is a progressive condition that frequently leads to right ventricular (RV) remodeling. Aldosterone promotes vascular and RV remodeling. The upregulation of steroidogenic acute regulatory protein (StAR)...
2.
Horio T, Iwashima Y, Yoshiyama M, Fukuda D, Hasegawa T, Fujimoto K
Blood Press Monit
. 2024 Sep;
29(6):305-311.
PMID: 39345201
Objective: Since hyperuricemia is a risk factor for cardiovascular disease and chronic kidney disease, it is necessary to pay attention to trends in uric acid levels when treating hypertensive patients...
3.
Horio T, Iwashima Y, Yoshiyama M, Fukuda D, Rai T, Fujimoto K
J Clin Hypertens (Greenwich)
. 2024 Sep;
26(10):1196-1200.
PMID: 39248193
The authors investigated the antihypertensive effect of sacubitril/valsartan (Sac/Val) when switching from other drugs and assessed whether brain natriuretic peptide (BNP) or plasma renin activity (PRA) before drug switching was...
4.
Horio T, Iwashima Y, Yoshiyama M, Fukuda D, Hasegawa T, Fujimoto K
Circ Rep
. 2024 Jul;
6(7):248-254.
PMID: 38989102
The blood pressure (BP)-lowering effect of sacubitril/valsartan (Sac/Val) is greater than that of angiotensin II receptor blockers (ARBs) but in in real-world clinical practice, Sac/Val is used in a variety...
5.
Yoshimura R, Hayashi O, Horio T, Fujiwara R, Matsuoka Y, Yokouchi G, et al.
Cardiol J
. 2024 Jul;
31(4):528-537.
PMID: 38949392
Introduction: Predictors of heart failure with recovered ejection fraction (HFrecEF) remain to be fully elucidated. This study investigated the impact of heart rate and its change on the recovery of...
6.
Ehara S, Mizutani K, Yamazaki T, Matsumoto K, Okai T, Yamaguchi T, et al.
Am Heart J Plus
. 2024 Apr;
10:100047.
PMID: 38560646
Background: Although intraplaque hemorrhage (IPH) has been identified as a key feature of rupture-prone plaques, noninvasive imaging-based features for its detection in coronary artery have not been clearly established. The...
7.
Hayashi H, Izumiya Y, Ishida T, Arima Y, Hayashi O, Yoshiyama M, et al.
Circ J
. 2023 Nov;
88(3):425-433.
PMID: 38008429
Background: Resistance exercise is beneficial in patients with lower extremity arterial disease. Muscle-derived exosomes contain many types of signaling molecules, including microRNAs (miRNAs). Here, we tested the hypothesis that exosomal...
8.
Yoshimura R, Hayashi O, Horio T, Fujiwara R, Matsuoka Y, Yokouchi G, et al.
J Clin Ultrasound
. 2023 Jun;
51(7):1131-1138.
PMID: 37363957
Objective: Clinical feature of heart failure with improved ejection fraction (HFimpEF) remains to be fully elucidated. The present study investigated the association of clinical and echocardiographic parameters with the subsequent...
9.
Ueda D, Yamamoto A, Ehara S, Iwata S, Abo K, Walston S, et al.
Eur Heart J Digit Health
. 2023 Jan;
3(1):20-28.
PMID: 36713993
Aims: We aimed to develop models to detect aortic stenosis (AS) from chest radiographs-one of the most basic imaging tests-with artificial intelligence. Methods And Results: We used 10 433 retrospectively...
10.
Yokoe S, Hayashi T, Nakagawa T, Kato R, Ijiri Y, Yamaguchi T, et al.
Hypertens Res
. 2022 Nov;
46(3):667-678.
PMID: 36376492
Previously, we showed that augmented O-linked N-acetylglucosaminylation (O-GlcNAcylation) mitigates cardiac remodeling in O-GlcNAc transferase-transgenic (Ogt-Tg) mice exposed to acute (2-week) intermittent hypoxia (IH) by suppressing nuclear factor of activated T...